TABLE 2.
Clinical characteristics of the enrolled patients.
| Tumor type | Gene status | Gender |
Age (Mean ± SD) | |
| Female | Male | |||
| NSCLC | 30 | 30 | 57.82 ± 7.26 | |
| EGFR mutant | 20 | 10 | 56.67 ± 7.20 | |
| EGFR wild-type | 10 | 20 | 58.97 ± 7.13 | |
| Breast cancer | 60 | 0 | 53.63 ± 10.53 | |
| HER2 positive | 30 | 0 | 54.03 ± 10.82 | |
| HER2 negative | 30 | 0 | 53.23 ± 10.21 | |
| Other | 9 | 11 | 53.23 ± 10.21 | |
| Total | 99 | 41 | 58.80 ± 13.45 | |
NCSLC, Non-small-cell lung cancer.